slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 22,531-22,560
Pages 1,349
Rows per page 30
Beat
22,531-22,560 of 40,452
29
The slide uses a process flow diagram to show trial progression and a list-based structure for clinical endpoints.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
30
The table displays patient characteristics (age, sex) and disposition (early discontinuation, death, progression) for three distinct dosing groups and the total population.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
31
The chart displays patient outcomes over time, with dots indicating progression and bars indicating stable disease.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
32
Includes a table of adverse events, box plots for cytokines (IL-1b, IL-6, CRP), and a longitudinal line chart for IFNy.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
33
The slide uses a staircase diagram to represent dose escalation levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
34
The slide presents a patient cohort table and a specific case study (Patient 6) showing M-spike protein and plasma cell levels over time.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
35
The slide presents clinical trial safety data including a table of adverse events and dot plots for inflammatory markers.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
06
Includes specific investor rollover details and pro forma credit statistics.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
07
Economic ownership calculated off of fully diluted share count of 185.4M inclusive of affiliated shares. Assumes Total Potential Diluted Aggregate Voting Power of 166.9MM votes.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
08
The slide tracks the progression of potential buyers from initial contact through to final bids, with a significant number of parties having passed or not engaged.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
09
The table uses a color-coded legend for negative outcomes (red X for no interest, double red X for re-confirmed no interest, yellow double X for not engaged).Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
10
Includes a timeline of events leading up to a final bid of $24.90.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
11
Includes footnotes regarding data sources and dates.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
12
Includes annotations for specific proposal price points (Unaffected, Violet IOI, Violet Revised IOI 1/2, Current Proposal, Orange Counter Proposal 1/2).Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
13
The slide uses a line chart format to contrast actuals (black), Street estimates (dashed blue), and Management projections (solid green).Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
14
Includes historical data (Actuals) and projections for 2022E-2025E.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
15
Includes reference data for historical trading ranges and analyst price targets.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
16
Data sourced from Capital IQ, Thomson Consensus, and Company Management.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
17
Includes median benchmarks for peer groups and management/street estimates for Orange.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & ProofLoop · Benchmark Gap1 hit
18
Includes sensitivity analysis for NTM multiples and discounted future share prices.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
19
Project Orange, Preliminary and Confidential Draft, Page 19.Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
20
Includes a highlighted section for management-approved extrapolations (CY26E-CY32E).Morgan Stanley | Investment Banking Pitch Book | 28 slides · Morgan Stanley
Regulatory filing Investment bank Beat · Evidence & Proof1 hit
08
New York Community Bancorp | Results Presentation Deck | 26 slidesNew York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
09
The table compares five specific asset quality ratios across three categories: NYCB, S&P U.S. BMI Banks Index, and Peers.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
10
New York Community Bancorp | Results Presentation Deck | 26 slidesNew York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
11
The slide uses a pie chart to show portfolio concentration and a bulleted list for qualitative highlights and specific performance metrics.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
12
The slide presents a historical bar chart of the loan portfolio alongside a table of originations and net charge-offs, plus a summary of portfolio statistics.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
13
The slide uses a table to demonstrate portfolio diversification and risk metrics (LTV) across different regions.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
14
The slide uses a bar chart to show portfolio size over time and a table for origination and charge-off data.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Business Model1 hit
15
Includes a bar chart showing portfolio growth and a table detailing loan types, pricing, and risk standards.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Financials1 hit